臍帶血庫服務市場按服務類型、應用、最終用戶、交付模式、處理方法、儲存期限和細胞類型分類的全球預測（2025-2032 年）

預計到 2032 年臍帶血銀行服務市場將成長 1,008.3 億美元，複合年成長率為 13.29%。

重點介紹將臍帶血庫置於臨床創新、營運複雜性、不斷變化的法規和相關人員決策的框架內

臍帶血庫處於臨床創新、以患者為中心的醫療服務以及複雜營運交付的交匯點。過去十年，幹細胞科學和轉化醫學的進步增強了臍帶血衍生產品的治療前景，而採集、處理和冷凍保存技術的改進也為臨床醫生和家屬提供了更多實用選擇。同時，不斷發展的法律規範以及對品質和可追溯性日益成長的期望，重新定義了整個臍帶血產業的營運標準。

本導言透過識別影響決策的關鍵服務模式、臨床和研究用途以及典型的最終用戶交互，將讀者置於當前的生態系統中。它還強調了科學機會與物流現實之間的相互作用，並強調了管治、報銷動態和組織夥伴關係如何影響採用路徑。本導言著重於可操作的情況而非盲目的樂觀，為後續分析設定了參數，並強調了相關人員必須監控的核心因素，以便在快速成熟的市場中保持韌性和敏捷性。

分析正在改變臍帶血採集、處理、儲存和管理方式的技術、臨床和監管變化

在技​​術日趨成熟、臨床模式不斷變化以及法規環境日益複雜化的推動下，臍帶血庫領域正在經歷一場變革。技術進步縮短了處理時間，提升了細胞活力指標，從而推動了對新型治療方法的探索，並擴大了臨床適應症的研究範圍。同時，用於捐贈者追蹤、知情同意管理和生物庫庫存管理的數位平台的整合，提高了透明度和營運效率，從而支持更高水準的可追溯性和品質保證。

隨著再生醫學應用和細胞療法研究與傳統移植途徑日益交織，臨床模式也正在改變。這種融合正在拓展臍帶血儲存單位的潛在效用，同時也挑戰生物樣本庫改進處理和儲存通訊協定，以滿足多樣化的下游需求。監管機構正在就良好組織規範、資料管治和跨境物流提供更清晰的指導，鼓勵供應商投資合規系統和標準化文件。總而言之，這些變化正在創造一個更專業的市場環境，其中策略夥伴關係、互通性和可證明的成果正成為供應商之間的關鍵差異化因素。

對 2025 年美國關稅政策變化如何改變臍帶血業務的採購、物流和風險管理動態進行衡量評估。

美國2025年關稅政策的製定，為醫療產品和生物材料跨境運輸的全球供應鏈帶來了新的複雜性。這些措施將對支持臍帶血業務的耗材、冷凍保存設備和診斷劑的供應商，以及用於研究和臨床用途的生物樣本的國際運輸產生直接影響。實際上，關稅主導的成本調整將改變籌資策略，促使企業重新評估供應商多元化，並鼓勵在可行的情況下與國內製造商建立更緊密的採購關係。

營運影響不僅限於直接成本，還包括物流規劃、海關流程以及與國際合作夥伴的合約條款的變更。先前依賴精實全球供應鏈的組織正在重新評估庫存政策和緩衝庫存，以保障服務的連續性。此外，關稅也促使一些相關人員加快關鍵製造業務的本土化，並重新協商服務等級協議，以更好地反映當前的貿易風險。從策略角度來看，關稅環境凸顯了情境規劃、供應商風險評估和自適應採購框架的重要性，這些框架可以在保持臨床和研究連續性的同時，減輕業務中斷的影響。

全面的、細分主導的觀點服務模式、臨床應用、最終用戶、處理方法和細胞產品類型與現實的營運選擇相結合

細分領域的理解對於建立針對性的臍帶血庫服務提案和臨床路徑至關重要。按服務類型分類，提供者採用混合、私有和公共模式營運，每種模式都有其獨特的商業邏輯、知情同意框架和相關人員關係，這些都會影響入組、定價和合作機會。按應用分類，市場涵蓋再生醫學、研究和移植領域。心血管、肌肉骨骼和神經系統疾病領域對再生醫學的需求正在成長，需要特定的處理標準和細胞富集方法。研究應用分為學術研究和商業研究，學術研究著重於基礎發現，商業項目著重於產品開發和轉化研發管線。移植用例包括血液學、免疫學和腫瘤學疾病，臨床方案和相容性要求決定了儲存和搜尋方法。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

• 擴大先進冷凍保存技術的整合以提高細胞活力
• 公私混合臍帶血庫需求不斷成長，以最佳化資源利用率
• 擴大臍帶血幹細胞在再生醫學的臨床試驗
• 加強監管將促進臍帶血處理通訊協定的標準化
• 利用家用臍帶血套件和遠端醫療的分散收集模式的出現

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 臍帶血銀行服務市場（依服務類型）

• 混合
• 私人的
• 公共

9. 臍帶血銀行服務市場（依應用）

• 再生醫學
  • 心血管系統
  • 肌肉骨骼
  • 神經系統
• 研究
  • 學術的
  • 商業的
• 移植
  • 血液疾病
  • 免疫疾病
  • 腫瘤疾病

第 10 章臍帶血銀行服務市場（依最終用戶）

• 診所
• 醫院
• 研究所

第 11 章臍帶血銀行服務市場（依交付模式）

• 異地收集
• 現場取貨

第 12 章臍帶血銀行服務市場（依處理方法）

• 單核細胞分離
• MSC富集
• 體積縮減

第13章臍帶血銀行服務市場（依儲存期限）

• 長期儲存
• 短期儲存

第 14 章臍帶血庫服務市場（依細胞類型）

• CD34陽性細胞
• 總有核細胞計數

第15章臍帶血銀行服務市場（按地區）

• 美洲
  • 北美洲
  • 拉丁美洲
• 歐洲、中東和非洲
  • 歐洲
  • 中東
  • 非洲
• 亞太地區

第16章臍帶血銀行服務市場（依類別）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第17章 臍帶血銀行服務市場（依國家）

• 美國
• 加拿大
• 墨西哥
• 巴西
• 英國
• 德國
• 法國
• 俄羅斯
• 義大利
• 西班牙
• 中國
• 印度
• 日本
• 澳洲
• 韓國

第18章競爭格局

• 2024年市佔率分析
• 2024年FPNV定位矩陣
• 競爭分析
  • Cord Blood Registry, LLC
  • Cryo-Cell International, Inc.
  • ViaCord, LLC
  • Vita 34 AG
  • Cordlife Group Limited
  • LifeCell International Private Limited
  • StemCyte, Inc.
  • Cryoviva Healthcare Private Limited
  • Cells4Life Limited
  • LifeCell International Private Limited

The Cord Blood Banking Services Market is projected to grow by USD 100.83 billion at a CAGR of 13.29% by 2032.

A focused introduction that situates cord blood banking within clinical innovation, operational complexity, regulatory evolution, and stakeholder decision frameworks

Cord blood banking occupies a distinctive intersection of clinical innovation, patient-centric care, and complex operational delivery. Over the past decade, advances in stem cell science and translational medicine have strengthened the therapeutic promise of cord blood-derived products, while improvements in collection, processing, and cryostorage have expanded practical options for clinicians and families alike. At the same time, evolving regulatory frameworks and heightened expectations around quality and traceability have redefined operational benchmarks across the sector.

This introduction situates the reader within the prevailing ecosystem by clarifying the principal service models, clinical and research applications, and typical end-user interactions that shape decision-making. It foregrounds the interplay between scientific opportunity and logistical realities, emphasizing how governance, reimbursement dynamics, and institutional partnerships influence adoption pathways. With a focus on actionable context rather than speculative optimism, the narrative establishes the parameters for subsequent analysis and underlines the core drivers that stakeholders must monitor to maintain resilience and agility in a rapidly maturing market.

An analysis of the transformative technological, clinical, and regulatory shifts reshaping how cord blood services are collected, processed, stored, and governed

The cord blood banking landscape is experiencing transformative shifts driven by technological maturation, shifting clinical paradigms, and a more sophisticated regulatory environment. Technological advances have reduced processing time and improved cell viability metrics, enabling new therapeutic explorations and expanding the range of clinical indications under investigation. Concurrently, the integration of digital platforms for donor tracking, consent management, and biobank inventory control is improving transparency and operational efficiency, which in turn supports higher standards of traceability and quality assurance.

Clinical paradigms are also changing as regenerative medicine applications and cell therapy research increasingly intersect with traditional transplantation pathways. This convergence broadens the potential utility of stored cord blood units while requiring biobanks to refine their processing and storage protocols to meet diverse downstream needs. Regulatory authorities are responding with more defined guidance on Good Tissue Practice, data governance, and cross-border logistics, prompting providers to invest in compliance systems and standardized documentation. Taken together, these shifts are fostering a more professionalized market environment where strategic partnerships, interoperability, and demonstrable outcomes are becoming the primary differentiators among providers.

A measured assessment of how United States tariff policy changes in 2025 have altered procurement, logistics, and risk management dynamics across cord blood operations

Tariff policy developments in the United States in 2025 introduced a new layer of complexity into global supply chains for medical goods and cross-border biological material movement. These measures have immediate implications for suppliers of consumables, cryopreservation equipment, and diagnostic reagents that support cord blood operations, as well as for international transfers of biological samples for research and clinical use. In practice, tariff-driven cost adjustments have altered procurement strategies, prompting a reassessment of supplier diversification and incentivizing closer sourcing relationships with domestic manufacturers where feasible.

Operational consequences extend beyond direct cost impacts to include shifts in logistics planning, customs clearance processes, and contract terms with international partners. Organizations that previously relied on lean global supply chains are re-evaluating inventory policies and buffer stocks to protect continuity of services. In addition, tariffs have encouraged some stakeholders to accelerate onshoring of critical manufacturing and to renegotiate service level agreements that better reflect current trade risks. From a strategic perspective, the tariff environment underscores the importance of scenario planning, supplier risk assessment, and adaptive procurement frameworks that can mitigate disruption while maintaining clinical and research continuity.

A comprehensive segmentation-driven perspective that aligns service models, clinical applications, end users, processing methods, and cellular product types to practical operating choices

Segment-level understanding is pivotal to crafting targeted service propositions and clinical pathways in cord blood banking. Based on Service Type, providers operate across hybrid, private, and public models, each presenting distinct commercial logics, consent frameworks, and stakeholder relationships that influence enrollment, pricing structures, and partnership opportunities. Based on Application, the market spans regenerative medicine, research, and transplantation. Regenerative medicine demand is being developed across cardiovascular, musculoskeletal, and neurological indications, requiring specific processing standards and cell enrichment approaches. Research applications are divided between academic and commercial research, with academic work driving fundamental discovery and commercial programs focused on product development and translational pipelines. Transplantation use cases include hematological disorders, immunological disorders, and oncological disorders, where clinical protocols and compatibility requirements dictate storage and retrieval practices.

Based on End User, activities are organized around clinics, hospitals, and research institutes, each demanding different engagement models, service level agreements, and reporting requirements. Based on Delivery Mode, collection strategies vary between off site collection and on site collection, affecting logistics, parental engagement, and chain-of-custody management. Based on Processing Method, laboratories deploy mononuclear cell isolation, MSC enrichment, and volume reduction techniques to prepare units for intended applications, and these methods have direct implications for yield, product specification, and downstream usability. Based on Storage Duration, facilities manage both long term storage and short term storage needs that reflect clinical readiness and research timelines. Based on Cell Type, cord blood services commonly differentiate handling for CD34 positive cells versus total nucleated cells, with processing, quality control, and release criteria aligned to the intended clinical or investigational use. Together, these segmentation lenses provide a comprehensive map for tailoring operational design, R&D prioritization, and market access activities.

Regionally nuanced insights into how regulatory diversity, healthcare infrastructure, and local manufacturing capacity influence cord blood adoption across major global markets

Regional dynamics play a critical role in shaping regulatory expectations, partner ecosystems, and adoption pathways for cord blood services. In the Americas, national regulatory agencies and payers are central to establishing pathways for clinical translation and adoption, and large healthcare networks often provide the primary points of clinician engagement and patient awareness campaigns. The Americas region also has notable capacity for domestic manufacturing of medical supplies, which influences procurement strategies and resilience planning.

In Europe, Middle East & Africa, regulatory heterogeneity and varying healthcare infrastructures require flexible commercialization approaches that emphasize compliance harmonization, localized partnerships, and tailored pricing strategies. Cross-border collaboration within this region often depends on mutual recognition frameworks and data transfer agreements that support research consortia and multicenter trials. Asia-Pacific presents a mix of rapid clinical adoption in some markets and nascent research development in others, with strong private-sector investment and growing biomanufacturing capabilities. Each region demonstrates unique strengths and constraints that influence decisions about where to prioritize clinical programs, where to invest in infrastructure, and how to design go-to-market models that accommodate local regulatory and reimbursement realities.

An appraisal of competitive and collaborative behaviours among market participants that highlights strategic investment areas, partnership models, and operational differentiators

Competitive dynamics in the cord blood arena are defined by a combination of service quality, clinical partnerships, technological capability, and reputational trust. Leading organizations have invested in end-to-end traceability systems, rigorous quality management, and proprietary processing techniques that enhance the clinical utility of stored units. Strategic collaborations with academic medical centers, clinical research networks, and device manufacturers have become important mechanisms for demonstrating real-world outcomes and securing referral pathways.

Mergers, partnerships, and vertical integration are observable strategies among market participants seeking to secure supply chains, broaden service offerings, and accelerate clinical validation. Investment in digital capabilities-covering consent management, cloud-based inventory control, and telemedicine-enabled client engagement-has emerged as a differentiator that improves customer experience and operational transparency. At the same time, smaller and specialized providers distinguish themselves through niche clinical focus, bespoke processing protocols, or deep relationships with regional healthcare systems. For stakeholders evaluating potential partners, the emphasis should be on validated quality systems, clinical evidence generation, and an ability to scale services in a compliant manner while preserving patient-centric care models.

Actionable strategic recommendations that blend supply chain resilience, digital modernization, clinical evidence generation, and partnership-driven capacity building for sustained growth

Industry leaders should prioritize investments that balance near-term operational robustness with long-term clinical and commercial positioning. First, strengthen supply chain resilience by diversifying critical suppliers, establishing redundancy for cryogenic equipment and consumables, and implementing contractual protections that reflect new trade realities. Such actions reduce exposure to procurement shocks and provide breathing room for strategic sourcing decisions.

Second, accelerate digital transformation to improve consent capture, chain-of-custody visibility, and client communication. Digital systems that integrate with electronic health records and support secure data exchange will streamline enrollment and retrieval workflows, enhancing clinician and patient satisfaction. Third, invest in targeted clinical evidence generation by sponsoring rigorous trials and observational studies across prioritized regenerative and transplantation indications; outcomes data will be decisive in payer discussions and clinical adoption. Fourth, pursue regulatory alignment and proactive compliance by engaging with authorities early, harmonizing quality systems to international standards, and documenting end-to-end traceability. Finally, cultivate strategic partnerships across academic centers, device suppliers, and logistics providers to create vertically integrated pathways from collection to therapeutic application. Collectively, these recommendations position organizations to capture emerging opportunities while mitigating operational and regulatory risks.

A transparent mixed-methods research approach combining primary stakeholder interviews, secondary literature synthesis, and systematic validation to produce actionable findings

The research methodology underpinning this analysis integrates primary qualitative interviews, secondary literature synthesis, and systematic data validation to ensure robustness and relevance. Primary engagement included structured interviews with clinical leaders, operational managers, and regulatory specialists to capture real-world constraints, emerging use cases, and adoption barriers. These conversations informed thematic coding and ensured that operational insights reflected pragmatic realities rather than theoretical constructs.

Secondary research encompassed review of peer-reviewed literature, regulatory guidance documents, technical white papers, and vendor specifications to triangulate technology trends and compliance expectations. Findings from primary and secondary sources were reconciled through cross-validation exercises, where discrepant inputs were resolved by returning to subject-matter experts or by examining recent regulatory announcements for clarification. The approach prioritized transparency in assumptions, reproducibility of analytic steps, and traceable linkage between evidence and implication. Ethical considerations and data privacy were embedded throughout the methodology, with attention to anonymization where interviewees provided proprietary or sensitive operational details. This mixed-methods approach supports a balanced, evidence-driven perspective that is actionable for commercial, clinical, and policy audiences.

A concise concluding synthesis that links technological progress, operational excellence, and evidence generation to the future clinical and commercial viability of cord blood services

In conclusion, cord blood banking stands at an inflection point where technological progress, shifting clinical applications, and evolving regulatory expectations are converging to redefine value propositions. Organizations that combine rigorous quality management, targeted clinical evidence generation, and adaptive supply chain strategies will be best positioned to translate scientific potential into sustained clinical utility. The evolving tariff and trade environment highlights the importance of resilience and local sourcing options, while advances in digital platforms are enabling more seamless interactions between families, clinicians, and biobanks.

Strategic clarity around segmentation-service model, application focus, end-user engagement, delivery mode, processing method, storage duration, and cell type-will enable providers to align capabilities to market needs and to pursue partnerships that amplify clinical impact. Ultimately, pragmatic investment in operational excellence, regulatory alignment, and evidence-based clinical programs will generate the credibility and performance required to realize the broader promise of cord blood-derived therapies and research initiatives.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Increasing integration of advanced cryopreservation technologies to enhance cell viability
• 5.2. Growing demand for private-public hybrid cord blood banks to optimize resource utilization
• 5.3. Expanding clinical trials exploring cord blood-derived stem cells in regenerative medicine
• 5.4. Heightened regulatory scrutiny driving standardization of cord blood processing protocols
• 5.5. Emergence of decentralized collection models leveraging home-based cord blood kits and telehealth

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cord Blood Banking Services Market, by Service Type

• 8.1. Hybrid
• 8.2. Private
• 8.3. Public

9. Cord Blood Banking Services Market, by Application

• 9.1. Regenerative Medicine
  • 9.1.1. Cardiovascular
  • 9.1.2. Musculoskeletal
  • 9.1.3. Neurological
• 9.2. Research
  • 9.2.1. Academic
  • 9.2.2. Commercial
• 9.3. Transplantation
  • 9.3.1. Hematological Disorders
  • 9.3.2. Immunological Disorders
  • 9.3.3. Oncological Disorders

10. Cord Blood Banking Services Market, by End User

• 10.1. Clinics
• 10.2. Hospitals
• 10.3. Research Institutes

11. Cord Blood Banking Services Market, by Delivery Mode

• 11.1. Off Site Collection
• 11.2. On Site Collection

12. Cord Blood Banking Services Market, by Processing Method

• 12.1. Mononuclear Cell Isolation
• 12.2. MSC Enrichment
• 12.3. Volume Reduction

13. Cord Blood Banking Services Market, by Storage Duration

• 13.1. Long Term Storage
• 13.2. Short Term Storage

14. Cord Blood Banking Services Market, by Cell Type

• 14.1. CD34 Positive Cells
• 14.2. Total Nucleated Cells

15. Cord Blood Banking Services Market, by Region

• 15.1. Americas
  • 15.1.1. North America
  • 15.1.2. Latin America
• 15.2. Europe, Middle East & Africa
  • 15.2.1. Europe
  • 15.2.2. Middle East
  • 15.2.3. Africa
• 15.3. Asia-Pacific

16. Cord Blood Banking Services Market, by Group

• 16.1. ASEAN
• 16.2. GCC
• 16.3. European Union
• 16.4. BRICS
• 16.5. G7
• 16.6. NATO

17. Cord Blood Banking Services Market, by Country

• 17.1. United States
• 17.2. Canada
• 17.3. Mexico
• 17.4. Brazil
• 17.5. United Kingdom
• 17.6. Germany
• 17.7. France
• 17.8. Russia
• 17.9. Italy
• 17.10. Spain
• 17.11. China
• 17.12. India
• 17.13. Japan
• 17.14. Australia
• 17.15. South Korea

18. Competitive Landscape

• 18.1. Market Share Analysis, 2024
• 18.2. FPNV Positioning Matrix, 2024
• 18.3. Competitive Analysis
  • 18.3.1. Cord Blood Registry, LLC
  • 18.3.2. Cryo-Cell International, Inc.
  • 18.3.3. ViaCord, LLC
  • 18.3.4. Vita 34 AG
  • 18.3.5. Cordlife Group Limited
  • 18.3.6. LifeCell International Private Limited
  • 18.3.7. StemCyte, Inc.
  • 18.3.8. Cryoviva Healthcare Private Limited
  • 18.3.9. Cells4Life Limited
  • 18.3.10. LifeCell International Private Limited

LIST OF FIGURES

• FIGURE 1. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2024 VS 2032 (%)
• FIGURE 13. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2024 VS 2032 (%)
• FIGURE 15. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 30. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 31. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 32. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 33. CORD BLOOD BANKING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 34. CORD BLOOD BANKING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. CORD BLOOD BANKING SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HYBRID, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HYBRID, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HYBRID, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HYBRID, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HYBRID, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PRIVATE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PRIVATE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PUBLIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PUBLIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ACADEMIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ACADEMIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COMMERCIAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY OFF SITE COLLECTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY OFF SITE COLLECTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY OFF SITE COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY OFF SITE COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY OFF SITE COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY OFF SITE COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ON SITE COLLECTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ON SITE COLLECTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ON SITE COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ON SITE COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ON SITE COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ON SITE COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MONONUCLEAR CELL ISOLATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MONONUCLEAR CELL ISOLATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MONONUCLEAR CELL ISOLATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MONONUCLEAR CELL ISOLATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MONONUCLEAR CELL ISOLATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MONONUCLEAR CELL ISOLATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MSC ENRICHMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MSC ENRICHMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MSC ENRICHMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MSC ENRICHMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MSC ENRICHMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MSC ENRICHMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY VOLUME REDUCTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY VOLUME REDUCTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY VOLUME REDUCTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY VOLUME REDUCTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY VOLUME REDUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY VOLUME REDUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY LONG TERM STORAGE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY LONG TERM STORAGE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY LONG TERM STORAGE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY LONG TERM STORAGE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY LONG TERM STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY LONG TERM STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SHORT TERM STORAGE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SHORT TERM STORAGE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SHORT TERM STORAGE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SHORT TERM STORAGE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SHORT TERM STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SHORT TERM STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CD34 POSITIVE CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CD34 POSITIVE CELLS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CD34 POSITIVE CELLS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CD34 POSITIVE CELLS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CD34 POSITIVE CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CD34 POSITIVE CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TOTAL NUCLEATED CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TOTAL NUCLEATED CELLS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TOTAL NUCLEATED CELLS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TOTAL NUCLEATED CELLS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TOTAL NUCLEATED CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TOTAL NUCLEATED CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 183. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 184. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 185. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 186. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 187. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 188. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 189. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
• TABLE 190. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2032 (USD MILLION)
• TABLE 191. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
• TABLE 192. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
• TABLE 193. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
• TABLE 194. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2025-2032 (USD MILLION)
• TABLE 195. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 196. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 197. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 198. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 199. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2024 (USD MILLION)
• TABLE 200. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2025-2032 (USD MILLION)
• TABLE 201. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 202. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 203. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 204. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
• TABLE 205. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 206. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 207. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 208. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 209. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 210. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 211. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
• TABLE 212. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2032 (USD MILLION)
• TABLE 213. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
• TABLE 214. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
• TABLE 215. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
• TABLE 216. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2025-2032 (USD MILLION)
• TABLE 217. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 218. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 219. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 220. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 221. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2024 (USD MILLION)
• TABLE 222. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2025-2032 (USD MILLION)
• TABLE 223. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 224. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 225. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 226. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
• TABLE 227. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 228. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 229. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 230. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 231. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 232. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 233. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
• TABLE 234. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2032 (USD MILLION)
• TABLE 235. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
• TABLE 236. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
• TABLE 237. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
• TABLE 238. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2025-2032 (USD MILLION)
• TABLE 239. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 240. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 241. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 242. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 243. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2024 (USD MILLION)
• TABLE 244. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2025-2032 (USD MILLION)
• TABLE 245. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 246. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 247. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 248. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 251. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 252. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 254. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 255. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
• TABLE 256. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2032 (USD MILLION)
• TABLE 257. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
• TABLE 258. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
• TABLE 259. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
• TABLE 260. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2025-2032 (USD MILLION)
• TABLE 261. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 262. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 265. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2024 (USD MILLION)
• TABLE 266. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2025-2032 (USD MILLION)
• TABLE 267. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 268. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 269. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 270. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
• TABLE 271. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 272. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 273. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 274. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 275. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 276. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 277. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
• TABLE 278. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2032 (USD MILLION)
• TABLE 279. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
• TABLE 280. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
• TABLE 281. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2024 (USD MILLION)
• TABLE 282. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2025-2032 (USD MILLION)
• TABLE 283. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 284. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 285. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 286. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 287. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2024 (USD MILLION)
• TABLE 288. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2025-2032 (USD MILLION)
• TABLE 289. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2024 (USD MILLION)
• TABLE 290. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2025-2032 (USD MILLION)
• TABLE 291. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 292. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
• TABLE 293. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 294. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 295. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 296. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 297. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 298. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 299. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE,